Element Launches New Pharmaceutical Testing Service
Element Materials Technology introduced its Rapid Response Pharmaceutical Testing Service, providing expedited testing and focusing on various requirements including active ingredients and final drug products, extractables and leachables, degradation production, and elemental impurities.
A case study done by the service using headspace gas chromatography mass spectrometry (HS-GC–MS) identified a volatile organic substance, cyclohexanone (1).
“We understand the critical importance of timely and precise testing in the pharmaceutical industry, and our new service is designed to address these needs head-on,” Iain Gibb, general manager of Element’s Manchester, UK lab, said in a press release.
Reference
(1) Ludlow, M. Characterization of Adhesive Related Leachable Deriving from Medical Infusion Bag. Element. Element Materials Technology, 2024. https://www.element.com/nucleus/2024/characterisation-of-adhesive-leachable (accessed 2024-03-21).
TD-GC–MS and IDMS Sample Prep for CRM to Quantify Decabromodiphenyl Ether in Polystyrene Matrix
April 26th 2024At issue in this study was the certified value of decabromodiphenyl ether (BDE 209) in a polystyrene matrix CRM relative to its regulated value in the EU Restriction of Hazardous Substances Directive.
LC–MS/MS-Based System Used to Profile Ceramide Reactions to Diseases
April 26th 2024Scientists from the University of Córdoba in Córdoba, Spain recently used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to comprehensively profile human ceramides to determine their reactions to diseases.
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.
